# Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients

> **NCT03271567** · — · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 100 (actual)

## Conditions studied

- Active Tuberculosis
- Tuberculosis, Extrapulmonary
- Tuberculosis, Pulmonary

## Interventions

- **DIAGNOSTIC_TEST:** Nanodisk-MS assay

## Key facts

- **NCT ID:** NCT03271567
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-28
- **Primary completion:** 2019-07-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-02-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03271567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03271567, "Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03271567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
